Navigation Links
Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Date:2/12/2008

d special and acquisition-related charges

(f) Included in cumulative effect in change in accounting principle, net

SCHERING-PLOUGH CORPORATION

Report for the period ended December 31 (unaudited):

GAAP Net Sales by Key Product

(Dollars in millions) Fourth Quarter Full Year

2007 2006 % 2007 2006 %

GLOBAL

PHARMACEUTICALS a/ $2,963 $2,211 34% $10,173 $8,561 19%

REMICADE 455 337 35% 1,648 1,240 33%

NASONEX 271 253 7% 1,092 944 16%

PEGINTRON 239 208 15% 911 837 9%

TEMODAR 234 189 23% 861 703 22%

CLARINEX /

AERIUS 174 164 6% 799 722 11%

CLARITIN RX 93 78 19% 391 356 10%

AVELOX 115 103 12% 384 304 26%

INTEGRILIN 91 85 7% 332 329 1%

REBETOL 71 75 (6%) 277 311 (11%)

CAELYX 66 49 33% 257 206 25%

INTRON A 57 57 - 233 237 (2%)

SUBUTEX /

SUBOXONE 57 51 11% 220 203 8%

PROVENTIL /

ALBUTEROL CFC 41 55 (25%) 207 203 2%

ASMANEX 41 36 16% 162 103 57%

ELOCON 37 33 10% 156 141 11%

FORADIL 25 28 (11%) 102 94 8%

NOXAFIL 29 10 N/M 89 19 N/M

FOLLISTIM c/ 57 - N/M 57 - N/M

NUVARING c/ 45 - N/M 45 - N/M

<
'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
2. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
5. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
6. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
9. Schering-Plough Completes Acquisition of Organon BioSciences
10. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
11. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Nov.23/PRNewswire/--PearlTherapeuticsInc.,abiophar...hetreatmentofchronicrespiratorydiseases,todayannou...fDirectors.Mr.Rosenhas25yearsofexperienceinthephar...olesatGileadSciencesandALZACorporation.Hisappointm...x. ,, "Howiebringsawealthofproductdevelopment,c...
(Date:11/20/2009)...20 Veridiam (www.veridiam.com) won...pany category at the 2009 Workplace Excellence Awa...iety for Human Resources Management and recognize ...es. ,, Veridiam was one of nine winners, select..., honored at the recent awards ceremony. San Diego...
(Date:11/20/2009).... 20 Cell Therapeutics, ...that the Ninth Circuit Court of Appeals reversed a...ld be allowed to pursue all of its claims against ...ict Court for trial. CTI filed a complaint agains...sement consultant for CTI,s product TRISENOX, in 2...
(Date:11/19/2009)...19 Danish Prince Joachim inaugurat...plant in Kalundborg, Denmark, on Wednesday, Novemb...d largest 2nd generation ethanol demonstration bio...d in the plant,s innovative process for converting...as the first to market with commercial enzymes for...
Breaking Biology Technology:Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2
...Principle with U.S. Attorney,s Office; ...gain Increases 2007 Earnings Guidance and Introduc...Inc. (Nasdaq:,CEPH) today reported third quarter 2...sales of $457.2 million for the third quarter of 2...dance. Basic loss per common,share for the third q...
...c and the Aflac Cancer Center for partne...MBUS, Ga., Nov. 8 Last night, the relationship th...e Aflac Cancer Center and,Blood Disorders Service ...th a U.S. Chamber of Commerce,s Corporate Citizens... television personality, Ed McMahon in,Washington,...
...dical,Innovations (Amex: IMA ) today announced th... Inc. for the worldwide manufacture and,distributi...um, the primary,causative agent of tuberculosis. T...odies for the detection of Lipoarabinomannan (LAM)...rrent mycobacterial infection,(including Tuberculo...
Other Biology Technology:Cephalon Announces Strong Third Quarter Financial Results 2Cephalon Announces Strong Third Quarter Financial Results 3Cephalon Announces Strong Third Quarter Financial Results 4Cephalon Announces Strong Third Quarter Financial Results 5Cephalon Announces Strong Third Quarter Financial Results 6Cephalon Announces Strong Third Quarter Financial Results 7Cephalon Announces Strong Third Quarter Financial Results 8Cephalon Announces Strong Third Quarter Financial Results 9Cephalon Announces Strong Third Quarter Financial Results 10Cephalon Announces Strong Third Quarter Financial Results 11Cephalon Announces Strong Third Quarter Financial Results 12Cephalon Announces Strong Third Quarter Financial Results 13Cephalon Announces Strong Third Quarter Financial Results 14Cephalon Announces Strong Third Quarter Financial Results 15Cephalon Announces Strong Third Quarter Financial Results 16Cephalon Announces Strong Third Quarter Financial Results 17Cephalon Announces Strong Third Quarter Financial Results 18Aflac Honored with Corporate Citizenship Award 2Aflac Honored with Corporate Citizenship Award 3Inverness - Chemogen Establish Exclusive License for TB Antibodies 2
(Date:11/22/2009)...ember 18, 2009 -- A butterfly,s proboscis looks li...-- but it works more like a paper towel, according...pes to borrow the tricks of this piece of insect a...uid inside of cells. , Kornev will present his w...erican Physical Society,s (APS) Division of Fluid ...
(Date:11/21/2009)...vember 20,2009 / b3c newswire / - KINAXO Biotech...cing round, gaining two new investors in the compa...NAXO reports that Jrgen Schumacher has been electe..., KINAXO shareholders Axel Ullrich, Hellmut Kirc...tutional investors Mountain Partners, BioM, High-T...
(Date:11/20/2009)...ve all read studies about the health benefits of h...e molecular level, where amino acids known as cyst...le than when paired up with other cysteines. , N...ng with colleagues in Belgium, have discovered a n...es. The research appears in the Nov. 20 issue of t...
Breaking Biology News(10 mins):KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3Saving the single cysteine: New antioxidant system found 2United Therapeutics Corporation Announces Stock Split To Be Effected as a Stock Dividend 13786 1United Therapeutics Corporation Announces Stock Split To Be Effected as a Stock Dividend 13786 2Cell Metabolism Publishes Novel TGR5 Mediated Mechanism for the Treatment of Diabetes and Obesity 13784 1Cell Metabolism Publishes Novel TGR5 Mediated Mechanism for the Treatment of Diabetes and Obesity 13784 2Cell Metabolism Publishes Novel TGR5 Mediated Mechanism for the Treatment of Diabetes and Obesity 13784 3Two Treatments Equally Effective for Chronic Pelvic Pain 55939 1Two Treatments Equally Effective for Chronic Pelvic Pain 55939 2
...howed that a fruit fly gene is crucial for determi...nd how the transformation initially proceeds. Unde...how adorable children become surly teenagers. , Wh...ely begin metamorphosis ?maturation from an immatu...st genetic mutation found to cause early maturatio...
...e University of North Carolina Hospitals arrived i...in and a glowing track record in helping to repair...blocked coronary arteries and perform gastric bypa...l is a robotic machine, the da Vinci Surgical Syst...tly is the only gynecological oncology program in ...
...ink between two biochemical pathways that plants u...s that scientists have long believed worked indepe...ys of immunity work may one day help researchers b...thogens, said David Mackey, the study,s lead autho...rop science at Ohio State University . , He and h...
Other Biology News:MWG Biotech expands siMAX?siRNA portfolio with new scales, lengths and design tools 2MWG Biotech expands siMAX?siRNA portfolio with new scales, lengths and design tools 3MWG Biotech expands siMAX?siRNA portfolio with new scales, lengths and design tools 4Screen all at risk for HIV, plus pregnant women 2Screen all at risk for HIV, plus pregnant women 3Study: Plants use dual defense system to fight pathogens 2
PIP Array from Echelon Biosciences Inc.
...rf Reference Series 2000 Pipette is a synonym for ... robust design, and superior operating comfort. It...e the measuring stroke and blow-out as well as eje...p" system ensures utmost accuracy and precision. E...
Goat Anti-Human STMN2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human PAEP Monoclonal Antibody, Unconjugated, Clone 6G2 from Novus Biologicals
Biology Products: